Confirmation

EP4284796

CRYSTAL FORM OF 6-(CYCLOPROPANECARBOXAMIDO)-4-((2-METHOXY-3-(1-METHYL-1H-1,2,4-TRIAZOL-3-YL)PHENYL)AMINO)-N-(METHYL-D3)PYRIDAZINE-3-CARBOXAMIDE

  • :
    EP einkaleyfi: EP einkaleyfi tilnefnt til gildistöku á Íslandi
  • :
    28.1.2022
  • :
    16.4.2025
  • :
    22704232.2
  • :
    27.1.2042
  • :
    27.1.2026
  • :
    CRYSTAL FORM OF 6-(CYCLOPROPANECARBOXAMIDO)-4-((2-METHOXY-3-(1-METHYL-1H-1,2,4-TRIAZOL-3-YL)PHENYL)AMINO)-N-(METHYL-D3)PYRIDAZINE-3-CARBOXAMIDE

28.1.2022
16.4.2025
27.1.2026
  • :
    Bristol-Myers Squibb Company
  • :
    Route 206 and Province Line Road, Princeton, NJ 08543, US
  • :
    ROSSO, Victor W.
  • :
    Princeton, New Jersey 08543, US
  • :
    202163143769 P
  • :
    29.1.2021
  • :
    US
  • :
    US2022014261
  • :
    28.1.2022
  • :
    C07D 403/12, A61K 31/501, A61P 29/00